ADACEL POLIO (Sanofi-Aventis Australia Pty Ltd)
Product name
ADACEL POLIO
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
40 working days (255)
Active ingredients
diphtheria toxoid; pertactin; pertussis filamentous haemagglutinin; pertussis fimbriae 2 + 3; pertussis toxoid; poliovirus; tetanus toxoid
Registration type
EOI
Indication
ADACEL POLIO (suspension for injection) now may also be administered during pregnancy for prevention of pertussis in young infants via transplacental antibody transfer from the pregnant woman to the fetus.